361 Capital’s Prestige Consumer Healthcare PBH Stock Holding History

361 Capital’s Portfolio PBH Stock Details PBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$622K	Sell	16,547 -2,563	-13%	-$103K	0.29%	189
2020 Q1	$701K	Sell	19,110 -17,675	-48%	-$686K	0.32%	157
2019 Q4	$1.49M	Sell	36,785 -40,545	-52%	-$1.51M	0.41%	66
2019 Q3	$2.68M	Buy	+77,330	New	+$2.55M	0.5%	61
2017 Q2	–	Sell	-18,116	Closed	-$1.01M	–	203
2017 Q1	$1.01M	Buy	+18,116	New	+$999K	0.22%	87

Other funds holding PBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

361 Capital's PBH Position: Q2 2020 in Review

361 Capital reduced its Prestige Consumer Healthcare (PBH) stake by 13% in Q2 2020, selling an estimated $103K and leaving 16,547 shares worth $622K. The position accounts for 0.29% of the portfolio, ranked #189.

361 Capital first reported a position in PBH in Q1 2017 and has held it in 5 quarters since. The position peaked at $2.68M in Q3 2019. 253 funds tracked by Wall St. Rank hold PBH as of Q2 2020.

361 Capital held 16,547 shares of Prestige Consumer Healthcare worth $622K as of Q2 2020.
361 Capital sold 2,563 Prestige Consumer Healthcare shares in Q2 2020, an estimated $103K.
Prestige Consumer Healthcare made up 0.29% of 361 Capital's portfolio in Q2 2020, its #189 holding.
361 Capital first reported a position in Prestige Consumer Healthcare in Q1 2017 and has held it in 5 quarters since.
361 Capital's Prestige Consumer Healthcare position peaked at $2.68M in Q3 2019.
253 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2020.

Based on 361 Capital's 13F filing for Q2 2020, filed 14 Aug 2020.